Cancer stem cells (CSCs) are defined as a subpopulation of malignant tumor cells with
selective capacities for tumor initiation, self‐renewal, metastasis, and unlimited growth into …

Since cancer stem cells (CSCs) were first identified in leukemia in 1994, they have been
considered promising therapeutic targets for cancer therapy. These cells have self-renewal …

Cells with “stemness” and tumor-initiating properties have been isolated from both
hematological and solid tumors. These cells denominated as cancer stem cells (CSCs) …

Tumorigenic cancer stem cells (CSCs) represent a subpopulation of cells within the tumor
that express genetic and phenotypic profiles and signaling pathways distinct from the other …

Cancer is a multifactor and multistep process that is affected intrinsically by the genetic and
epigenetic makeup of tumor cells and extrinsically by the host microenvironment and …

Cancer stem cells (CSCs) are a subpopulation of cancer cells that are capable of self-
renewal, proliferation, differentiation, plastic adaptation, and immune regulation, thereby …

Cancer stem cells (CSCs), also known as tumor-initiating cells, are characterized by an
increased capacity for self-renewal, multipotency, and tumor initiation. While CSCs …

Cancer stem cells (CSCs), initially identified in leukemia in 1994, constitute a distinct subset
of tumor cells characterized by surface markers such as CD133, CD44, and ALDH. Their …

Cancer stem cells (CSCs) have important roles in tumour development, relapse and
metastasis; the intrinsic self-renewal characteristics and tumorigenic properties of these cells …

Tumor relapse and metastasis remain major obstacles for improving overall cancer survival,
which may be due at least in part to the existence of cancer stem cells (CSCs). CSCs are …